VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
38 hedge funds and large institutions have $1.29M invested in Viracta Therapeutics, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
74% less capital invested
Capital invested by funds: $4.91M → $1.29M (-$3.61M)
Holders
38
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$116K | |
| 2 | +$32K | |
| 3 | +$15.8K | |
| 4 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
+$9.89K |
| 5 |
Renaissance Technologies
New York
|
+$6.41K |
Top Sellers
| 1 | -$1.97M | |
| 2 | -$47.8K | |
| 3 | -$40.2K | |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$33.5K |
| 5 |
Morgan Stanley
New York
|
-$24K |